HOME >> BIOLOGY >> NEWS
VIB and Johnson & Johnson set up a new fund

Ghent, Belgium -- VIB, the Flanders Interuniversity Institute for Biotechnology, Johnson & Johnson's Corporate Office of Science and Technology (COSAT) and Johnson & Johnson Pharmaceutical Research and Development (J&J PRD) have established a first Proof-of-Concept Fund at the value of 500 000 EUR. The primary goal of the Fund is to foster VIB proof-of-concept research (technologies, molecular mechanisms of disease ...). The Fund focuses on collaborations between different VIB departments and has to validate frontline inventions in life sciences research at VIB.

Proof-of-Concept Fund The further purpose of this program is to identify research with potential for commercialization. Projects should be at a developmental stage at which carefully designed studies are likely to provide proof of concept. This project is unique in Europe, it is the first time that such a fund has been supported by COSAT and J&J PRD at a European University or Academic Institution. The aim of this fund, is to sow the seeds of (a) larger collaboration(s) with J&J and to stimulate interactions between researchers of J&J PRD and COSAT on the one hand and VIB on the other hand. The Fund is really meant to form the first building blocks of a bridge between two major players (one in the industrial and one in the academic world) in biotechnology and pharmaceutical sciences in Flanders, Belgium.

The winning projects The projects are pre-screened by a VIB committee and the final selection will be done by COSAT and J&J PRD team. 4 Projects will be selected on the basis of several criteria (most important criteria are: scientific relevance of research topic, excellence of the proposed research, commercial potential and added value of interdepartmental collaboration). Each winning project receives 125 000 EUR, which is sufficient to pay one post doctoral researcher and his bench fee for one year. In this manner one hopes to sow the seeds for larger collaborations betwee
'"/>

Contact: Sooike Stoops
info@vib.be
329-244-6611
VIB, Flanders Interuniversity Institute of Biotechnology
23-Oct-2006


Page: 1 2

Related biology news :

1. Gladstones Deepak Srivastava receives E. Mead Johnson Award for achievement in pediatrics
2. Johnson & Johnson announces call for nominations
3. Johnson & Johnson names selection committee for Dr. Paul Janssen Award for Biomedical Research
4. HSPHs Walter Willett wins Bristol-Myers Squibb/Mead Johnson Freedom to Discover Award
5. Conservation International and SC Johnson partner again to offset carbon impacts

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... 2020 , ... In its June 22 online post, business and technology news ... M.D., Ph.D., founder and director of stem cell biotechnology company Asymmetrex . Superb ... that starting July 5 it would begin offering free tissue stem cell counting ...
(Date:6/13/2020)... ... June 11, 2020 , ... ... a significant expansion of its forensic genealogy team. Bode’s Forensic Genealogy Service ... proven forensic genealogy and DNA analysis methods. The team has added experienced genealogists, ...
(Date:6/5/2020)... (PRWEB) , ... June 04, 2020 , ... “Although we ... health and well-being of our attendees, staff, and the public. We remain committed ... and safe ways to collaborate virtually,” said Julie Sutcliffe, President of WMIS. ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 29, 2020 , ... The Interlocal Purchasing System (TIPS), ... membership, recently named BioFit Engineered Products an Awarded Vendor. Awarded Vendor ... seating, cafeteria tables, book trucks and carts at discounted pricing without the delay ...
(Date:6/28/2020)... (PRWEB) , ... June 26, 2020 , ... ... association representing security solutions providers, today announced its strong opposition to the recently ... bill would impose a blanket ban on most federal use of nearly all ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... innovative CNS therapies, today announced that it has filed an Investigational New Drug ... Phase 2b clinical trial of its lead drug candidate NBTX-001 in patients with ...
(Date:6/11/2020)... ... June 09, 2020 , ... Reducing carbon emissions has been ... the Paris Agreement to stock market dips, ways to reduce CO2 is something we ... their portfolio. Most of the biofuels being produced today are created from recycled cooking ...
Breaking Biology Technology:
Cached News: